Cargando…

The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers

BACKGROUND: Roux-en-Y gastric bypass (RYGB) surgery is currently the most effective treatment of obesity, although limited by availability and operative risk. The gut hormones Glucagon-like peptide-1 (GLP-1), Peptide YY (PYY), and Oxyntomodulin (OXM) are elevated postprandially after RYGB, which has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Tricia, Behary, Preeshila, Tharakan, George, Minnion, James, Al-Najim, Werd, Albrechtsen, Nicolai J. Wewer, Holst, Jens J., Bloom, Stephen R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2017
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505203/ https://www.ncbi.nlm.nih.gov/pubmed/28379519 http://dx.doi.org/10.1210/jc.2017-00469

Ejemplares similares

Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass
por: Tharakan, George, et al.
Publicado: (2017)

On the relationship between glucose absorption and glucose‐stimulated secretion of GLP‐1, neurotensin, and PYY from different intestinal segments in the rat
por: Kuhre, Rune E., et al.
Publicado: (2017)

The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction
por: Jones, Ben, et al.
Publicado: (2021)

Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study
por: Alexiadou, Kleopatra, et al.
Publicado: (2020)

L‐Arginine Increases Postprandial Circulating GLP‐1 and PYY Levels in Humans
por: Amin, Anjali, et al.
Publicado: (2018)

Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity
por: De Silva, Akila, et al.
Publicado: (2012)

Glucagon‐like peptide‐1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP‐1 receptors
por: Ronn, Jonas, et al.
Publicado: (2017)

Plasma levels of glucagon but not GLP-1 are elevated in response to inflammation in humans
por: Modrzynska, Justyna, et al.
Publicado: (2021)

GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass
por: Guimarães, Marta, et al.
Publicado: (2015)

Methods and Guidelines for Measurement of Glucagon in Plasma
por: Holst, Jens J., et al.
Publicado: (2019)

Serum lipase activity and concentration during intravenous infusions of GLP‐1 and PYY (3‐36) and after ad libitum meal ingestion in overweight men
por: Schmidt, Julie B., et al.
Publicado: (2016)

Presence and dynamics of leptin, GLP-1, and PYY in human breast milk at early postpartum
por: Schueler, Jessica, et al.
Publicado: (2013)

CCK‐1 and CCK‐2 receptor agonism do not stimulate GLP‐1 and neurotensin secretion in the isolated perfused rat small intestine or GLP‐1 and PYY secretion in the rat colon
por: Modvig, Ida M., et al.
Publicado: (2020)

Bone Perspectives in Functional Hypothalamic Amenorrhoea: An Update and Future Avenues
por: Behary, Preeshila, et al.
Publicado: (2022)

Angiotensin II Type 1 Receptor-Dependent GLP-1 and PYY Secretion in Mice and Humans
por: Pais, Ramona, et al.
Publicado: (2016)

The Effect of Exercise Intensity on Total PYY and GLP-1 in Healthy Females: A Pilot Study
por: Hallworth, Jillian R., et al.
Publicado: (2017)

The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents
por: Psichas, A, et al.
Publicado: (2015)

The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs
por: Wewer Albrechtsen, Nicolai J., et al.
Publicado: (2016)

Weight Loss by Low-Calorie Diet Versus Gastric Bypass Surgery in People With Diabetes Results in Divergent Brain Activation Patterns: A Functional MRI Study
por: Salem, Victoria, et al.
Publicado: (2021)

Antagonizing somatostatin receptor subtype 2 and 5 reduces blood glucose in a gut- and GLP-1R–dependent manner
por: Jepsen, Sara L., et al.
Publicado: (2021)

Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass
por: Jonsson, Isabella, et al.
Publicado: (2021)

Oxyntomodulin analogue increases energy expenditure via the glucagon receptor
por: Scott, R., et al.
Publicado: (2018)

A high carbohydrate, but not fat or protein meal attenuates postprandial ghrelin, PYY and GLP-1 responses in Chinese men
por: Parvaresh Rizi, Ehsan, et al.
Publicado: (2018)

The Gut Hormones PYY(3-36) and GLP-1(7-36 amide) Reduce Food Intake and Modulate Brain Activity in Appetite Centers in Humans
por: De Silva, Akila, et al.
Publicado: (2011)

Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapy
por: Kjeldsen, Sasha A.S., et al.
Publicado: (2023)

Glucagon Receptor Signaling and Lipid Metabolism
por: Galsgaard, Katrine D., et al.
Publicado: (2019)

GLP‐1 Is a Coronary Artery Vasodilator in Humans
por: Clarke, Sophie J., et al.
Publicado: (2018)

The Importance of Interpreting Urine Calcium:Creatinine Ratio in PHPT Within Ethnic Context
por: Abdel-Malek, Mariana, et al.
Publicado: (2021)

The VIP/VPAC1R Pathway Regulates Energy and Glucose Homeostasis by Modulating GLP-1, Glucagon, Leptin and PYY Levels in Mice
por: Sanford, Daniel, et al.
Publicado: (2022)

Health care professionals from developing countries report educational benefits after an online diabetes course
por: Wewer Albrechtsen, Nicolai J., et al.
Publicado: (2017)

Failure of sucrose replacement with the non-nutritive sweetener erythritol to alter GLP-1 or PYY release or test meal size in lean or obese people
por: Overduin, Joost, et al.
Publicado: (2016)

No Evidence That Circulating GLP-1 or PYY Are Associated with Increased Satiety during Low Energy Diet-Induced Weight Loss: Modelling Biomarkers of Appetite
por: Lim, Jia Jiet, et al.
Publicado: (2023)

Salivary PYY: A Putative Bypass to Satiety
por: Acosta, Andres, et al.
Publicado: (2011)

Identification of ADAM12 as a Novel Basigin Sheddase
por: Albrechtsen, Reidar, et al.
Publicado: (2019)

Appetite control and gastrointestinal hormonal behavior (CCK, GLP-1, PYY 1–36) following low doses of a whey protein-rich nutraceutic
por: Sukkar, Samir Giuseppe, et al.
Publicado: (2013)

EFFECT OF THE INGESTION OF THE PALM OIL AND GLUTAMINE IN SERUM LEVELS OF GLP-1, PYY AND GLYCEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS SUBMITTED TO METABOLIC SURGERY
por: TAKEUTI, Tharsus Dias, et al.
Publicado: (2014)

Intermittent Hypoxia Up-Regulates Gene Expressions of Peptide YY (PYY), Glucagon-like Peptide-1 (GLP-1), and Neurotensin (NTS) in Enteroendocrine Cells
por: Shobatake, Ryogo, et al.
Publicado: (2019)

Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials
por: DeFronzo, Ralph A., et al.
Publicado: (2016)

Effects of 2 Novel PYY(1-36) Analogues, (P(3)L(31)P(34))PYY(1-36) and PYY(1-36)(Lys(12)PAL), on Pancreatic Beta-Cell Function, Growth, and Survival
por: Lafferty, Ryan A, et al.
Publicado: (2019)

Satiety, but not total PYY, is increased with continuous and intermittent exercise
por: Holmstrup, ME, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hkl6mf5lfp6257g9u60d1lb39m